TIGIT and COVID-19: These findings corroborate previous reports describing the dysregulation of the immune system among COVID-19 patients with the worst outcome and suggest that the immunoregulatory mechanisms performed by FOXP3+T regulatory cells are biased, favoring the TIGIT+ Treg subset.